Article premium, As Blue March gains momentum, early detection remains crucial in the fight against colorectal cancer, particularly as incidence rates rise in younger adults. L’équipe de coordination de Mars Bleu, de droite à gauche, Jackie Collet, Anne Brisard, Élodie Coulon, Justine Bertron et Jocelin Corvaisier. | MAINE LIBRE fermer L’équipe de coordination de Mars … Read more
The Rising Tide of Colorectal Cancer in Younger Adults: A Wake-Up Call A growing number of individuals in their 30s and 40s are receiving a colorectal cancer diagnosis, challenging conventional understanding of the disease. Marisa Peters, a 44-year-old Los Angeles mother of three, embodies this shift. For years, her symptoms – rectal bleeding, changes in … Read more
The Rising Tide of Early-Onset Breast Cancer: A Vietnamese Perspective Recent data from Bach Mai Hospital in Vietnam reveals a concerning trend: an increase in breast cancer diagnoses among younger women, some as young as 28 and 31, often without any noticeable symptoms. Over the first three days of March 2026, the hospital’s Nuclear Medicine … Read more
Chemo and Fitness: How Exercise is Becoming a Vital Part of Cancer Treatment For decades, rest was the standard prescription for cancer patients undergoing chemotherapy. Now, a growing body of research, spearheaded by experts like Dr. Karen Mustian at the Wilmot Cancer Institute, is flipping that script. A recent study published in JNCCN-Journal of the … Read more
AI Pathologists: The Future of Cancer Diagnosis is Here Artificial intelligence is poised to revolutionize cancer diagnosis, not by replacing pathologists, but by working alongside them. Modern research from the University of Surrey and Monash University demonstrates a groundbreaking approach where AI learns to defer to human experts strategically, reducing workload and improving accuracy. The … Read more
Fertility Treatments and Cancer Risk: What the Latest Research Reveals A recent study published in JAMA Network Open has shed light on the complex relationship between medically assisted reproduction (MAR) and cancer risk in women. While overall cancer incidence among those who undergo fertility treatments remains comparable to the general population, certain cancer types appear … Read more
Cancer Immunotherapy: A New Target Emerges as Cells ‘Barf’ Proteins Researchers have identified a surprising location for a key protein, Src, on the surface of cancer cells – a place it shouldn’t be. This discovery, reported in Science, could unlock new avenues for immunotherapy, particularly for solid tumors, which have historically been hard to treat … Read more
The Future of Food and Cancer Prevention: What to Expect Diet plays a crucial role in cancer risk, alongside genetics, environment, and lifestyle. Certain foods, when consumed regularly, can contribute to biological mechanisms that increase long-term risk. Experts are increasingly focused on how to adapt our diets without resorting to overly restrictive measures. Processed Meats: … Read more
Immunotherapy Plateau? New Data Shifts Focus Back to Radiation in Small Cell Lung Cancer A recent international clinical trial, NRG-LU005, has delivered a nuanced message in the fight against limited-stage small cell lung cancer (LS-SCLC). While the addition of immunotherapy drug atezolizumab to standard chemoradiation didn’t significantly improve overall survival, a surprising trend emerged: twice-daily … Read more
Lung Cancer Breakthrough: Targeting Aging to Improve Treatment for Older Patients Researchers at the University of Gothenburg have pinpointed a protein, ATF4, that plays a crucial role in how lung cancer spreads, particularly in older individuals. This discovery, published in Nature, offers a potential new avenue for precision medicine and could significantly improve outcomes for … Read more